Thromboembolic Events in Gastric Cancer: High Incidence in Patients Receiving Irinotecan- and Bevacizumab-Based Therapy
- 10 April 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (11), 2574-2576
- https://doi.org/10.1200/jco.2005.81.908
Abstract
Purpose: To summarize the end points used by the United States Food and Drug Administration (FDA) to approve new cancer drug applications over the last 13 years.Keywords
This publication has 15 references indexed in Scilit:
- Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II studyAnnals Of Oncology, 2004
- Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803Journal of Clinical Oncology, 2004
- Treatment of metastatic esophagus and gastric cancer.Seminars in Oncology, 2004
- Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trialAnnals Of Oncology, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003
- The Hypercoagulable State of Malignancy: Pathogenesis and Current DebateNeoplasia, 2002
- CPT‐11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinomaCancer, 2002
- Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent PanelJournal of Clinical Oncology, 2001
- Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric CancerJournal of Clinical Oncology, 1999